WhaleWatch
Sign inGet started
Smart Money Alert
Senores Pharmaceuticals Limited logo

Senores Pharmaceuticals Limited

DecreasedQuarterly
SENORESPharmaceuticalsMarket Cap₹6K Cr
Stake
1.95% → 1.36%
Holding
6.29 L shares
Change
−2.69 L shares
As of
Sept 2026
Since alert−7.8%₹1,318.40 → ₹1,215.30
Nifty 50−2.4%
AS
Astorne Capital
Foreign Investor
The move

Astorne Capital decreased its stake in Senores Pharmaceuticals from 1.95% to 1.36%, selling 2,68,822 shares.

About Senores Pharmaceuticals Limited
+ FollowVisit stock

A pharmaceutical manufacturer that produces complex generic medicines certified by global regulatory authorities including the FDA and WHO. Incorporated in 2015, the company focuses on developing and supplying affordable, high-quality pharmaceutical formulations to domestic and international markets. Its operations center on manufacturing specialized generics that address critical therapeutic areas while maintaining stringent international quality standards and compliance requirements.

About Astorne Capital
+ FollowVisit investor

Astorne Capital is a Singapore-based variable capital company managed by fund manager Prosperitas Capital, investing in Indian listed and SME equities.

Get the next move the moment it happens.
Follow Astorne Capital and Senores Pharmaceuticals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Senores Pharmaceuticals Limited shareholdersAstorne Capital's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Senores Pharmaceuticals Limited
More moves in Senores Pharmaceuticals Limited
Bajaj Finserv Mutual FundIncreased
Bajaj Finserv Mutual Fund increased its stake in Senores Pharmaceuticals Limited from 1.19% to 1.79%, purchasing 2,76,025 shares.
16 Oct 2026
Read more
HSBC Mutual FundDecreased
HSBC Mutual Fund reduced its stake in Senores Pharmaceuticals Limited from 3.44% to 2.87%, selling 2,62,802 shares.
16 Oct 2026
Read more
Mahindra Manulife Mutual FundIncreased
Mahindra Manulife Mutual Fund increased its stake in Senores Pharmaceuticals from 1.14% to 1.21%, buying 31,937 shares.
16 Oct 2026
Read more
Trust Mutual Fund
Direction, size, price and stake change for this move, with what it means for the company.
16 Oct 2026. Sign in to see this move
Aditya Birla Sun Life InsuranceDecreased
Aditya Birla Sun Life Insurance decreased its stake in Senores Pharmaceuticals from 1.62% to 1.28%, selling 1,56,984 shares.
16 Oct 2026
Read more
See all moves
AS
More moves by Astorne Capital
Mehul Telecom Limited
Direction, size, price and stake change for this move, with what it means for the company.
20 Oct 2026. Sign in to see this move
Arisinfra Solutions LimitedIncreased
Astorne Capital increased its stake in Arisinfra Solutions Limited from 1.44% to 3.09%, raising its holding from 11,79,695 shares to 25,26,366 shares. This quarterly change includes 5,00,000 shares already accounted for in prior disclosures. The transaction took place via a rights issue.
ARIS19 Oct 2026
Read more
Ratnaveer Precision Engineering LimitedExited
Astorne Capital is no longer listed among the key shareholders of Ratnaveer Precision Engineering Limited. This absence indicates that the investor either completely exited the previous 1.81 percent position or trimmed it below the 1 percent reporting threshold.
RATNAVEER19 Oct 2026
Read more
Agi Infra LimitedExited
Astorne Capital is no longer listed among the major shareholders of Agi Infra Limited, having either completely exited or reduced its last disclosed 2.71 percent stake to below the 1 percent reporting threshold.
AGIIL16 Oct 2026
Read more
Vintage Coffee And Beverages LimitedExited
Astorne Capital has vanished from the latest shareholder list for Vintage Coffee And Beverages Limited, indicating either a complete exit or a trim below the 1 percent reporting threshold from its previously disclosed 1.78 percent stake.
VINCOFE13 Oct 2026
Read more
See all moves